IDEX Raises FY26 EPS Outlook to $8.85, Shares Jump 7%
IEX sits 48% above its 52-week low of $157.25.
Summary
IDEX reported Q2 results and raised its full-year adjusted EPS guidance to $8.70-$8.85, up from $8.35-$8.55, while maintaining organic sales growth of 3-4%. The company also issued Q3 guidance of $2.20-$2.25 EPS on 5-7% organic growth. The stock surged 7% pre-market, reflecting the magnitude of the beat and improved visibility. This follows a strong Q1 and record Q2 orders and sales noted in an 8-K earlier today. The raised outlook signals sustained momentum in Health & Science and other segments, driven by strong AI data center demand.
At the time of this announcement, IEX was trading at $232.55 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $16.6B. The 52-week trading range was $157.25 to $231.70. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: dpa-AFX.